Badia Mariona, Casanova José Manuel, Serviá Lluís, Montserrat Neus, Codina Jordi, Trujillano Javier
Department of Intensive Care Medicine, Arnau de Vilanova Hospital, Lleida, Spain.
Department of Dermatology, Arnau de Vilanova Hospital, IRBLLEIDA, Lleida, Spain.
Crit Care Res Pract. 2020 Sep 26;2020:9729814. doi: 10.1155/2020/9729814. eCollection 2020.
Dermatological problems are not usually related to intensive medicine because they are considered to have a low impact on the evolution of critical patients. Despite this, dermatological manifestations (DMs) are relatively frequent in critically ill patients. In rare cases, DMs will be the main diagnosis and will require intensive treatment due to acute skin failure. In contrast, DMs can be a reflection of underlying systemic diseases, and their identification may be key to their diagnosis. On other occasions, DMs are lesions that appear in the evolution of critical patients and are due to factors derived from the stay or intensive treatment. Lastly, DMs can accompany patients and must be taken into account in the comprehensive pathology management. Several factors must be considered when addressing DMs: on the one hand, the moment of appearance, morphology, location, and associated treatment and, on the other hand, aetiopathogenesis and classification of the cutaneous lesion. DMs can be classified into 4 groups: life-threatening DMs (uncommon but compromise the patient's life); DMs associated with systemic diseases where skin lesions accompany the pathology that requires admission to the intensive care unit (ICU); DMs secondary to the management of the critical patient that considers the cutaneous manifestations that appear in the evolution mainly of infectious or allergic origin; and DMs previously present in the patient and unrelated to the critical process. This review provides a characterization of DMs in ICU patients to establish a better identification and classification and to understand their interrelation with critical illnesses.
皮肤病问题通常与重症医学无关,因为它们被认为对危重症患者的病情发展影响较小。尽管如此,皮肤病表现(DMs)在重症患者中相对常见。在极少数情况下,DMs将成为主要诊断,并且由于急性皮肤衰竭而需要强化治疗。相比之下,DMs可能是潜在全身性疾病的一种反映,其识别可能是诊断的关键。在其他情况下,DMs是在危重症患者病情发展过程中出现的病变,是由住院或强化治疗相关因素引起的。最后,DMs可能伴随患者出现,在综合病理管理中必须予以考虑。处理DMs时必须考虑几个因素:一方面是出现时间、形态、位置以及相关治疗,另一方面是皮肤病变的病因发病机制和分类。DMs可分为4组:危及生命的DMs(不常见但危及患者生命);与全身性疾病相关的DMs,其中皮肤病变伴随需要入住重症监护病房(ICU)的疾病;危重症患者管理继发的DMs,这考虑了主要在感染性或过敏性病程中出现的皮肤表现;以及患者先前存在且与危重症过程无关的DMs。本综述对ICU患者的DMs进行了描述,以建立更好的识别和分类,并了解它们与危重症疾病的相互关系。